Anrikefon (HSK21542) acetate is a peripherally restricted kappa-opioid receptor (KOR) agonist with an IC50 of 0.54 nM, an EC50 of 2.41 pM, and a Kₐ of 0.068 nM against human KOR, and it shows high selectivity over µ and delta opioid receptors. Anrikefon exerts analgesic effects by inhibiting behavioral responses associated with inflammatory, postoperative and neuropathic pain, and also exerts antipruritic effects by reducing itch-related behaviors. Anrikefon acetate can be used in the research of pain, pruritus, and pruritus associated with chronic kidney disease[1][2].
Molekulargewicht:
763.97
Reinheit:
99.68
CAS Nummer:
[2584931-05-3]
Formel:
C41H61N7O7
Target-Kategorie:
Opioid Receptor
Anwendungsbeschreibung:
MCE Product type: Peptides
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
